The Readout Loud
STAT
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring
22 minutes
Posted Jan 3, 2019 at 11:05 pm.
0:00
22:05
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Are megamergers bad for business? Is it time for biotech's biggest gathering to find a new home? And can a "need" be anything but "unmet"?
Previous
Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta
Next
Episode 43: A people's history of J.P. Morgan
← See all 424 episodes of The Readout Loud
